๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

3 recruiting trials

for Venentoclax

Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 Trial NCT07396480Phase 318 sites๐Ÿ“ Fuzhou๐Ÿ“ Guangzhou๐Ÿ“ Zhengzhou First Affiliated Hospital of Zhejiang University ยท Tests: Venetoclax in combination with fludarabine and melphalan, Fludarabine and Melphalan The Maintenance Treatment of "ITIVA" in AML Patients NCT06256627NA1 site๐Ÿ“ Zhengzhou Henan Cancer Hospital ยท Tests: recombinant human interference'- ฮฑ- 1b, interleukin-2, thalidomide, Venentoclax and Azacitidine Venetoclax Combined With Azacitidine for Consolidation Therapy in AML NCT07425782Phase 21 site๐Ÿ“ Suzhou The First Affiliated Hospital of Soochow University ยท Tests: Ara-C Group, VEN/AZA condsolidation
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy